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of this report. 
This report presents the results of the 18 CHIPRA Core Measures that were collected using MaineCare claims, 
Vital Statistics or survey data and reported to the Centers for Medicare and Medicaid Services (CMS) for FFY 
2013. Also included in this report are an additional three measures from the Improving Health Outcomes for 
Children (IHOC) project’s Master List of Pediatric Measures. In addition to presenting results in graphs and 
narrative, this report also provides measure definitions and background information about each measure topic.
This work was conducted under a Cooperative Agreement between the Maine Department of Health and 
Human Services and the Muskie School of Public Service at the University of Southern Maine and is funded 
under grant CFDA 93.767 from the U.S. Department of Health and Human Services, Centers for Medicare & 
Medicaid Services (CMS) authorized by Section 401(d) of the Child Health Insurance Program Reauthorization 
Act (CHIPRA). These contents do not necessarily represent the policy of the U.S. Department of Health and 
Human Services, and you should not assume endorsement by the Federal Government.
The views expressed are those of the authors and do not necessarily represent the views of either the Department 
or the School. For further information regarding this report, please contact Mary Lindsey Smith at mlsmith@
usm.maine.edu. For more information about the IHOC project, please contact Joanie Klayman at jklayman@
usm.maine.edu.
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Introduction
In February 2010, Maine and Vermont were awarded a five-year demonstration grant from the Centers for 
Medicare and Medicaid Services (CMS) to improve the quality of health care for children insured by Medicaid 
and the Children’s Health Insurance Program (CHIP). Maine’s Department of Health and Human Services’ 
(DHHS) Office of MaineCare Services (OMS) received the Improving Health Outcomes for Children (IHOC) 
grant in partnership with the Maine Center for Disease Control, the Muskie School of Public Service at the 
University of Southern Maine, Vermont’s Medicaid Program, and the University of Vermont. 
In Maine, a key objective of the IHOC grant is to collect and report on the Initial Core Set of Children’s Health 
Care Quality Measures (referred to as the “CHIPRA Core Measures”), a set of 24 standardized, evidence-based 
measures identified by CMS for use by State Medicaid and CHIP programs.1 States submit results of the 
CHIPRA Core Measures to CMS once each year as a component of the CHIP Annual Report, a web-based 
reporting system (CARTS) that CMS and its contractors use to monitor the operations of Medicaid and CHIP 
programs. 
Although reporting of the Core Measures is currently not required by CMS, MaineCare reported results for 18 
of the measures in the Federal Fiscal Year 2013 (FFY 2013), with support from the IHOC project. Of the 18 
initial core set measures MaineCare is currently reporting on, 12 are claims-based, 3 are registry-based, 2 based 
on CMS 416 data and one survey measure. Sixteen of these measures are reported through the CHIP Annual 
Reporting System (CARTS) and the remaining two will be calculated by CMS using data from Maine’s CMS 
Form 416 reports.
This document presents the results of the 18 CHIPRA Core Measures that were collected using MaineCare 
claims, Vital Statistics or survey data and reported to CMS. These measures include:
• Well-child visits (3 measures)
• Access to primary care practitioners
• Chlamydia screening
• Appropriate testing for children with pharyngitis
• Emergency Department (ED) visits
• Asthma ED visits
• Follow-up care for children with ADHD medication
• Annual pediatric hemoglobin A1c testing
• Follow-up after hospitalization for mental illness
1 For more information about the CHIPRA Core Measures, see: http://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/
Quality-of-Care/CHIPRA-Initial-Core-Set-of-Childrens-Health-Care-Quality-Measures.html
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• Prenatal Care (2 measures)
• Live Births Weighing Less than 2,500 Grams
• Developmental screening 
• Preventative dental and dental treatment services2 
• Patient Experience of Care
In addition to the CHIPRA Core Measures, Maine providers collaborating with the IHOC project identified 
other quality measures to support quality improvement at the practice-level. Through a stakeholder feedback 
process, measures drawn from Bright Futures guidelines, Meaningful Use, and other sources were added to the 
CHIPRA Core Measures to create the Maine IHOC Pediatric Measures List, a set of quality, clinically relevant 
pediatric measures.
The document also presents results of measures from the IHOC Measure list not included among the CHIPRA 
Core Measures. The following “IHOC-only” measures were calculated using MaineCare claims:
• Well-child visits between 15 months and 3 years of age (IHOC #32), and between 7 and 11 years of age 
(IHOC #34).
• Asthma controller medication (IHOC #25) 
The goal of this document is to present the claims-based CHIPRA and IHOC measure results in a user-friendly 
format for IHOC project stakeholders. Measures are grouped by topic. For each topic, a Background section 
provides a brief description and rationale for collection.3 Next, we provide a general description of how each 
measure is defined, followed by the results. 
Most of the measures use a 12-month measurement period. To fulfill requirements of the CHIP Annual Report 
we used measurement periods that correspond to Federal Fiscal Years (FFY). Federal Fiscal Years run from 
October 1st of the prior year through September 30th of the year being described. For example, FFY 2013 
represents the period from October 1, 2012 through September 30, 2013.
Where available, we also include national 2012 HEDIS averages from Medicaid managed care plans along with 
Maine’s results. The Health Plan Employer Data and Information Set (HEDIS) is a set of performance measures 
developed by the National Committee for Quality Assurance (NCQA). HEDIS measures are widely used by 
employers, consumers, and Medicaid agencies to compare and monitor performance of health plans. Many 
of the CHIPRA Core Measures are HEDIS measures, and the NCQA publishes average results for selected 
measures each year.4 HEDIS averages are included to provide a point of comparison for the Maine results.
2 The two dental measures included in the CHIPRA core set, which are also EPSDT measures, are now reported with the other EPSDT measures on 
CMS-416 rather than in the CHIP Annual Report.
3 The background discussion for CHIPRA Core Measures is drawn from the Background Report for the Initial, Recommended Core Set of Children’s 
Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs. Available at: http://www.ahrq.gov/policymakers/chipra/overview/
background/corebackgrnd.pdf 
4 National Committee for Quality Assurance (October 2013). The State of Health Care Quality 2013. Available at: http://www.ncqa.org/tabid/836/
Default.aspx.
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Well-Child Visits (WCVs)
CHIPRA Measures W15, W34, AWC / IHOC Measures 31, 32, 33, 34, 35
Background 5
Current American Academy of Pediatrics (AAP) Bright Futures guidelines suggest that all children receive a 
well-child visit (WCV) at specific intervals depending on age. Well-child visits are the gateway to immunizations 
and early identification of problems. They provide opportunities to discuss developmental issues with parents 
and deliver evidence-based and other recommended specific preventive services. The CHIPRA Core measures 
include three well-child visit measures currently specified by National Committee for Quality Assurance 
(NCQA): 1) WCVs in the first 15 months of life; 2) WCVs in the 3rd, 4th, 5th, and 6th years of life; 3) WCVs 
in adolescence (ages 12 – 21). 
IHOC stakeholders noted the importance of measuring WCVs for two additional age ranges that are not 
included in the CHIPRA measures: WCVs between 15 months and 3 years of age (IHOC #32), and WCVs 
between 7 and 11 years of age (IHOC #34).
Measure Definition
These measures assess, for each age group, the number of children who received a well-child or preventive 
care visit from a primary care practitioner (including, for adolescents, an obstetrician-gynecologist) during the 
measurement year.
For the youngest group, children who turn 15 months during the measurement year and are continuously 
enrolled from 31 days after birth to 15 months of age are in the measure denominator.6 The number of visits is 
counted (0, 1, 2, 3, 4, 5, 6 or more visits) for this age group.
For children between 15 months and 3 years of age, children who turn 3 years old during the measurement 
year and are continuously enrolled between 15 months and 3 years of age are in the measure denominator. The 
number of visits is counted (0, 1, 2, 3) for this age group.
For 3-6 year-olds, 7-11 year-olds, and adolescents (12-21 years old) the criterion is at least one well-child visit 
with a primary care practitioner during the measurement year. The denominator population for each of these 
measures is defined by the age of the child at the end of the measurement year, and requires that the child be 
continuously enrolled during the year.
5 Throughout this document, much of the background information for each measure is drawn from the Background Report for the Initial, 
Recommended Core Set of Children’s Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs. Available at: http://www.ahrq.gov/
policymakers/chipra/overview/background/index.html.
6 “Continuously enrolled” means the child missed no more than one month of MaineCare eligibility in the measurement period. For 12 month 
measurement periods, the child must be enrolled for at least 11 months to be included in the denominator.
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Results
The results of the WCV measures for FFY 2009 through FFY 2013 are shown in Figures 1 – 3 and Table 1. 
Rates of well-child visits remained relatively constant over the 5-year measurement period.
Figure 1 shows the percentage of children enrolled in MaineCare with 0-1, 2-4, 5 or 6 or more total WCVs in 
the first 15 months of life. Two-thirds of enrolled children (67%) had at least 6 visits in the first 15 months, and 
81 percent had 5 or more visits. MaineCare’s rates for children having six or more WCVs where slightly higher 
than the 2012 HEDIS average of 64 percent.
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Figure 1
Number of Well-Child Visits in the First 15 Months
Source: MaineCare Claims Data 
Figure 2 shows the percentage of children age 15 months to 3 years with 0, 1, 2, or 3 total WCVs, the rate 
has steadily increased between FFY 2009 and FFY 2013. The number of children receiving the recommended 
three well-child visits between 15 months and three years increased by 4 percent between FFY 2012 and FFY 
Summary of Pediatric Quality Measures for Children Enrolled in MaineCare
Muskie School of Public Service       Cutler Institute for Health and Social Policy 5
2013, from 50% to 54%. Over the past five years the number of children between the ages of 15 months and 3 
years receiving the recommended number of well-child visits has increased by 8 percent over the past five years 
however, ten percent of the children in this age range had no WCVs.
11% 12% 11% 10% 10%
17% 17% 17% 15% 14%
26% 26% 25%
25%
22%
46% 45% 46% 50% 54%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
FFY2009
(n=5,826)
FFY2010
(n=6,520)
FFY2011
(n=6,555)
FFY2012
(n=6,617)
FFY2013
(n=6,617)
Pe
rc
en
ta
ge
 o
f C
hi
ld
re
n
3 +
2
1
0
Figure 2
Number of Well-Child Visits between 15 Months and 3 Years
Source: MaineCare Claims Data 
Figure 3 shows the percentage of children who had at least one WCV in the measurement year, by three different 
age ranges: ages 3 – 6, ages 7 – 11, and ages 12 – 21; rates in all three age categories have remained stable over 
the past 5 years. Notably, WCV rates decline considerably as children get older. For 3 to 6 year olds, about 63 
percent had at least one visit during the measurement year. For 7 to 11 year olds, the rate falls to 49 percent, and 
for adolescents, it falls further still to 39 percent. Note that MaineCare rates are lower than the HEDIS national 
average for FFY 2012: 10 percent lower for 3-6 year olds and 11 percent lower for adolescents.7
7 HEDIS did not measure visits for ages 7-11.
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Well-Child Visits- At Least One Visit Per Year
Measure 
Description
At least 1 
visit Total
At least 1 
visit Total
At least 1 
visit Total
At least 1 
visit Total
At least 1 
visit Total
WCVs, 3-6 Years 14,762 23,124 15,505 25,304 16,308 25,984 16,492 26,526 16,176 25,788
WCVs, 7-11 Years 12,754 27,246 12,950 28,856 13,868 29,618 14,713 30,811 14,768 30,432
WCVs, 12-21 Years 16,502 43,402 16,785 46,469 18,058 46,988 18,528 47,990 18,008 46,350
Number of Children Who had at Least One Well Child Visit by Age Cohort
FFY2009 FFY2010 FFY2011 FFY2012 FFY2013
Table 1
Source: MaineCare Claims Data 
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Access to Primary Care Practitioners (PCPs) 
CHIPRA Measure CAP / IHOC Measure 45
Background
The CHIPRA legislation specified that measures of availability of services be included in in the CHIPRA 
Core measure set. Availability of services is an important topic, given the many reports from national studies 
on the lack of providers and some providers’ unwillingness to serve Medicaid patients. The expert panel 
convened by the federal Agency for Healthcare Research and Quality (AHRQ) and CMS to review and make 
recommendations for the CHIPRA Core measures noted that “…realized access to care (e.g., utilization of 
primary care practitioners) [is an] incomplete measure of availability because the reasons for lack of utilization 
could go well beyond lack of availability (e.g., parents don’t perceive a need for the service). However, realized 
access is a piece of availability and a way to measure access under capitated primary care arrangements.”8
The panel also noted that the Access to PCP measure is only a proxy measure for availability of services; it 
cannot be considered a true availability of services measure because it deals with only primary care, and because 
the reasons for non-use of primary care services may vary, from lack of availability, to lack of time, to lack of 
perceived need, and other factors.9
This measure can be considered important from two perspectives. From a payer perspective, it is good to know 
whether enrolled children are getting any care. Access to primary care practitioners is essential for children to 
have well-child visits and the opportunity for social and developmental screening, two measures also included 
in the CHIPRA Core measure set.
Measure Definition
For children aged 12-24 months, and 25 months-6 years, this measure assesses the receipt of one or more 
visits with a primary care provider during the measurement year. For children aged 7-11 and 12-19 years, the 
measure assesses the receipt of one or more visits with a primary care provider during the measurement year 
or the year prior to the measurement year. Continuous enrollment for the younger two age groups is required 
for the measurement year. For the two older age groups, continuous enrollment is required for both sequential 
measurement years.
8&9 Report available at: http://www.ahrq.gov/policymakers/chipra/overview/background/next-steps3.html.
Summary of Pediatric Quality Measures for Children Enrolled in MaineCare
Muskie School of Public Service       Cutler Institute for Health and Social Policy 8
Results
Figure 4 shows the percentage of children in each age group who had at least one visit with their PCP in the 
5 measurement years. MaineCare’s performance on this measure is excellent across all age categories. Realized 
access among the youngest children is nearly universal, at 97 percent and rates of access to PCPs are around 90 
percent for the other three age groups as well. These rates are at or above the FFY 2012 rates reported by states 
in the 2012 Annual Report on the Quality of Care for Children in Medicaid and CHIP and are also at or above 
the 2012 HEDIS Averages.10
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Access to Primary Care Practitioners- At least one visit per year
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Source: MaineCare Claims Data
10  Report available at: http://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Quality-of-Care/Downloads/2012-Ann-Sec-Rept.
pdf.
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Chlamydia Screening for Women age 16 – 20 Years
CHIPRA Measure 9 / IHOC Measure 37
Background
Screening to identify health conditions for early intervention with effective treatments is a primary purpose of 
preventive (well-care) visits. Screening for chlamydia, a sexually transmitted infection, of sexually active females 
ages 16-20 was identified as an important screening because, if left untreated, it can cause pelvic inflammatory 
disease in women, a condition that can result in sterility. Chlamydia is easy-to-treat, but widespread. In 2010, 
1,307,893 cases of chlamydia infection were reported to the Centers for Disease Control (CDC), which is the 
largest number of cases ever reported to the CDC for any condition.11 This corresponds to a rate of 426 cases per 
100,000 population, an increase of 5.1% since 2009 and rates for women are over two and a half times the rate 
among men.12 Although Maine ranks 48th in reported chlamydia cases (3,094 in 2011), screening is essential 
to ensure that cases are not being missed and going untreated.13
Measure Definition
This measure assesses the extent to which at least one chlamydia test is given during the measurement year to 
women 16-20 years of age who were identified as sexually active and were enrolled in MaineCare for at least 11 
out of the 12 months during the measurement year.
Results
Figure 5 shows that 43 percent of sexually active women age 16 – 20 years enrolled in MaineCare had a 
chlamydia screening in FFY 2013. Screening rates were very similar across the five measurement years. Each year 
screening rates in Maine have fallen below the HEDIS average rates which have consistently remained around 
55 percent since FFY 2009.
11&12  Information gathered from the Center for Disease Control, National Overview of Sexually Transmitted Disease 9STDs), 2010 at: http://www.
cdc.gov/std/stats10/natoverview.htm.
13  Information gathered from the Kaiser Family Foundation, State Health Facts.org at: http://kff.org/other/state-indicator/chlamydia-cases/#.
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Chlamydia Screening for Women 
(Ages 16-20)
Source: MaineCare Claims Data
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Preventive Dental and Dental Treatment Services 
CHIPRA Measures PDENT, TDENT / IHOC Measures 38, 39
Background
Oral health problems are common, painful, and preventable. According to the CDC Oral Health Report in 
2011, tooth decay affects more than one-fourth of U.S. children aged 2–5 years and half of those aged 12–15 
years. About half of all children and two-thirds of adolescents aged 12–19 years from lower-income families 
have had decay.14 Ongoing dental services are essential to improve children’s oral health. 
Dental services are a required benefit for most Medicaid-eligible individuals under the age of 21, as a component 
of the Early Periodic Screening, Diagnosis and Treatment (EPSDT) program, and with the advent of CHIPRA, 
dental services are also a required benefit for CHIP enrollees. Two dental measures reported through CMS-416 
(a required report submitted by all EPSDT programs to CMS each year) are included in the CHIPRA core set: 
children receiving preventive dental services (CHIPRA PDENT / IHOC #38), and children receiving dental 
treatment services (CHIPRA TDENT, IHOC #39).
Measure Definition
Two EPSDT measures, Receipt of Preventive Dental Services and Dental Treatment Service assess the percent of 
children ages 1 to 20 who received dental services as a function of the number of children eligible for EPSDT 
services as shown on line 1 of the CMS-416 form.15 Children are counted as eligible for EPSDT services if they 
were enrolled in MaineCare for at least 3 consecutive months during the measurement year.
Results
Figure 6 shows results for the two measures related to dental services for children age 1-20 that are eligible for 
EPSDT services.16 Rates for both dental preventative and treatment rose between 2010 and 2011 but, since 
that time rate have remained relatively stable. Just over 32 percent of eligible children received preventive 
dental services in FFY 2013, up from 20 percent in FFY 2010. Over the past four years, the provision of dental 
treatment services has increased by 6 percent from 11 percent in FFY 2010 to 17 percent of eligible children 
received dental treatment in FFY 2013. 
14  http://www.cdc.gov/chronicdisease/resources/publications/AAG/doh.htm
15  “Dental Services” are identified using CDT or HCPCS codes D0100 – D9999. “Preventive Dental” are codes D1000 – D1999, and “Dental 
Treatment” are codes D2000 – D09999.
16  Note: The results of the two EPSTD dental measures presented here are data that were included in the FFY 2010 – 2012 CMS 416 Reports. Data 
for 2013 was run in April of 2014.
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Dental Services-
Prevention and Treatment
Source: MaineCare Claims Data
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Appropriate Testing for Children with Pharyngitis and 
Prescribed an Antibiotic
CHIPRA Measure CWP/ IHOC Measure 30
Background
Upper respiratory infections (URIs), including pharyngitis (inflammation of the throat), are among the most 
common reasons for children’s acute care encounters with health care providers. URIs often present opportunities 
for the overuse of antibiotics even though most URIs are time-limited and, if viral, cannot be cured with 
antibiotics. The purpose of the measure is to monitor and help reduce the unnecessary use of antibiotics by 
ensuring that antibiotics were not given without a diagnosis of streptococcal (strep) bacteria. Pharyngitis is 
measured because it was the leading diagnosis for 6.4 million visits to physician offices and hospital outpatient 
departments for all children under age 15 in 2006 nationally, providing many opportunities for inappropriate 
antibiotic use.17
Measure Definition
This measure assesses whether a strep test was administered for children 2-18 years in the 7-day period from 
3 days prior through 3 days after the first eligible episode date. An eligible episode is an outpatient visit with 
a diagnosis of pharyngitis at which an antibiotic was dispensed. The measure counts children who were 
continuously enrolled 30 days prior to the episode date through 3 days after the episode date.
Results
Figure 7 shows the rates of appropriate testing for children diagnosed with pharyngitis have increased slightly 
over the past five years (up 8%). In FFY 2013, 80 percent of children enrolled in MaineCare who were diagnosed 
with pharyngitis and prescribed an antibiotic had received a strep test. MaineCare’s rates for appropriate 
testing for children with pharyngitis have continually exceeded national HEDIS averages for testing; in 2013 
MaineCare’s rates were 12 percent higher than the HEDIS average of sixty-eight percent.
17  Background Report for the Initial, Recommended Core Set of Children’s Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs. 
Available at: http://www.ahrq.gov/policymakers/chipra/overview/background/index.html
Summary of Pediatric Quality Measures for Children Enrolled in MaineCare
Muskie School of Public Service       Cutler Institute for Health and Social Policy 14
72%
75%
80% 81% 80%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
FFY2009
(n=994)
FFY2010
(n=992)
FFY2011
(n=1,283)
FFY2012
(n=1,171)
FFY2013
(n=819)
Pe
rc
en
ta
ge
 o
f C
hi
ld
re
n
2012 HEDIS
Average-68%
Figure 7
Appropriate Testing for Children Diagnosed with Pharyngitis who are
Prescribed an Antibiotic ( Ages 2-18 )
Source: MaineCare Claims Data
Emergency Department (ED) Visits
CHIPRA Measure AMB / IHOC Measure 41
Background
Emergency departments are a critical feature of the U.S. health care delivery system. However, their availability 
and convenience compared to other care settings means that they may be used when traditional care settings 
would be more appropriate and less costly. The intent of using this measure is to reduce unnecessary ED visits.
The measure is potentially important to MaineCare, given that in 2006, Medicaid paid for 62 percent of all ED 
visits of children less than age 1 and they paid for 42 percent of all ED visits of children 1-17 years.18
18  Kilbreth, B., C. McGuire, C. Gray, T. Chitashviliand, and K. Finison (2009). Analysis of 2006 Maine. Emergency Department Utilization. 
Portland, ME: University of Southern Maine, Muskie School of Public Service
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Measure Definition
This measure assesses the average number of ED visits per 1,000 member months (rather than individual 
members). The measure breaks out the results by age: less than 1 year, 1-9 years, 10-19 years and the total of 
all ages.
Results
The results in Figure 8 show that the youngest children (under age 1) report the most ED visits however, the 
rates have continued to drop for all age categories over the past half-decade. For children under the age of one, 
rates dropped from a high of 80 visits per 1,000 member months in 2009 to only 40 visits in 2013. Rates of ED 
visits drop consistently as children age. Between 2009 and 2013 rates for individuals in the various age cohorts 
have dropped between 3 to 8 percent; in 2013 the overall average number of ED visits for all age cohorts was 46.
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Figure 8
Emergency Department Visits Per 1,000 Member Months
Source: MaineCare Claims Data
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Asthma Emergency Department (ED) Visit and Use of 
Appropriate Medications
CHIPRA Measure MMA / IHOC Measures 25, 42
Background
Asthma is the most prevalent chronic physical condition among children. In 2010, 7 million children had 
asthma, which is equal to one out of every eleven children19 As of 2007, 12.9 percent of children covered by 
Medicaid reported currently having asthma.20 In 2008, the CDC reported that 9.4 percent of Maine children 
had asthma.21
Children with asthma have higher rates of healthcare utilization and costs, in 2009 the average yearly cost of care 
for a child with asthma was $1,039.22 In the same year, one in five children with asthma went to an emergency 
department for an asthma related incident.23 Emergency department visits for asthma are important to measure 
because they are expensive and provide a gateway to hospitalization.
Asthma controller medicines are also important to measure because they help prevent asthma symptoms when 
taken every day as prescribed. The asthma controller measure (IHOC #25) is not part of the CHIPRA core set, 
but is included in Meaningful Use.
Measure Definition
The asthma ED visit measure assesses the percentage of children in MaineCare ages 2 through 20 diagnosed 
with asthma during the measurement year with one or more asthma-related ED visits. The measure does not 
require that a child be continuously enrolled in MaineCare to be included; the eligible population is defined by 
the age of the child and diagnosis of asthma, identified using ICD-9 codes in the claims. 
The asthma controller medication measure assesses the percentage of children enrolled in MaineCare ages 5 
through 21 years who were identified as having persistent asthma who were appropriately prescribed controller 
medication during the measurement year.
19  Information gathered from the Center for Disease Control, Asthma’s Impact on the Nation: Data from the CDC National Asthma Control 
Program available at: http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf
20  Information gathered from the Center for Disease Control, Asthma in Maine available at: http://www.cdc.gov/asthma/stateprofiles/asthma_in_
me.pdf
21  Information gathered from the Center for Disease Control, Asthma’s Impact on the Nation: Data from the CDC National Asthma Control 
Program available at: http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf
22  Information gathered from the Center for Disease Control, Asthma’s Impact on the Nation: Data from the CDC National Asthma Control 
Program available at: http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf
23  Information gathered from the Center for Disease Control, Asthma’s Impact on the Nation: Data from the CDC National Asthma Control 
Program available at:  http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf
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Results
Figure 9 shows that in FFY 2013, there were 9,479 children ages 2 – 20 enrolled in MaineCare who were 
identified as having asthma; of those, just over 7 percent had one or more visits to the ED because of their 
asthma during the year. Rates for asthma-related ED visits have remained just above or below 7 percent since 
FFY 2009 with the exception of FFY 2012 when rates increased slightly – nearly 9 percent.
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Figure 9
Asthma Patients with at Least 1 Asthma-Related 
Emergency Department Visit
Source: MaineCare Claims Data
Figure 10 shows the number of active asthma patients who were appropriately prescribed controller 
medications during the measurement year. Two age groups were measured, children ages 5-12 years and 12-21 
years. Over 90 percent of 5-12 year old children with asthma were prescribed controller medications in all five 
measurement years. Among the older age group (12-21 years) controller medication rates were slightly lower 
ranging from 89 percent in FFY 2009 to 88 percent in FFY 2013. These rates where comparable to 2012 
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HEIDIS Rates which were 90% for children ages 5 – 11 and 86% for children 12 - 18.24
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Figure 10
Children with Asthma Prescribed
Source: MaineCare Claims Data
24  National Committee for Quality Assurance (October 2013). The State of Health Care Quality 2013. Available at: http://www.ncqa.org/tabid/836/
Default.aspx.
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Follow-up Care for Children Prescribed ADHD Medication
CHIPRA Measure ADD / IHOC Measure 36
Background
The percentage of children estimated to have attention deficit hyperactivity disorder (ADHD) continues to grow, 
up from 3 percent in 2003 to 11 percent in 2011.25 This translates into more than 1 out of every 10  children 
between the ages of 4 – 17 having been diagnosed with ADHD in 2011.26 Estimates show that approximately 
six percent of children nationally take medication for ADHD. In 2011, 10.1% of children in Maine had a 
current diagnosis of ADHD, and 6.6% of those children were currently taking a medication for the disorder.27 
Since medications affect children differently, follow-up care for medicated children is critical for their health and 
well-being, as well as the treatment of their ADHD.
Measure Definition
This measure assesses the percentage of children newly prescribed ADHD medication that had at least three 
follow-up care visits within a 10-month period, one of which was within 30 days from the time the first ADHD 
medication was dispensed. The first 30 days are referred to as the Initiation Phase and the next nine months are 
referred to as the Continuation and Maintenance (C&M) phase. The measure is limited to children ages 6 – 
12 years. To be included in the denominator for the initiation phase, children must be enrolled in MaineCare 
continuously for four months prior to the medication dispensing date through 30 days after that date. To be 
included in the denominator for the C&M phase, children must be enrolled in MaineCare continuously for 
four months prior to the medication dispensing date through 10 months after that date. 
Results
Follow-up care for children prescribed ADHD medication has increased over the past five years during both 
the initiation phase and in continuation and care maintenance stage. Rates for both measures have improved 
significantly over the past five years (increasing nearly 20%) and far exceed the 2012 HEDIS averages. In FFY 
2013, there were a total of 1,114 children ages 6 – 12 enrolled in MaineCare who were identified as having 
received a prescription for ADHD and over two-thirds of those children (68%) received appropriate follow-
up care during the Initiation Phase. The results for the C&M phase are similar, with 65 percent of children in 
MaineCare receiving appropriate follow-up care for ADHD medications in FFY 2013.
25  Information gathered from the Centers for Disease Control report: Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated 
ADHD: United States, 2003—2011. Available at: http://www.cdc.gov/ncbddd/adhd/features/key-findings-adhd72013.html.
26  Information gathered from the Centers for Disease Control report: Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated 
ADHD: United States, 2003—2011. Available at: http://www.cdc.gov/ncbddd/adhd/data.html#cost.
27  Information gathered from the Centers for Disease Control report: Parent-Reported Diagnosis of ADHD by a Health Care Provider and 
Medication Treatment. Available at: http://www.cdc.gov/ncbddd/adhd/stateprofiles/stateprofile_maine.pdf
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Follow-Up Care for Children Prescribed
ADHD medication ( Ages 6-12 )
Source: MaineCare Claims Data
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Annual Pediatric Hemoglobin A1c Testing and 
Comprehensive Diabetes Care
CHIPRA Measure PA1C / IHOC Measure 43
Background
Health care providers and others are raising concerns about the rising rate of diabetes among children and 
adolescents. In 2010, the CDC reports that about 215,000 people younger than 20 years of age are diagnosed 
with diabetes (type 1 or type 2). This represents 0.26 percent of all people in this age group.28 That figure 
doesn’t include the substantial number of young people that are undiagnosed or considered to be pre-diabetic. 
Hemoglobin A1c (HbA1c) testing measures how close to normal blood glucose levels are maintained over time; 
therefore, it is an important indicator of management of the diabetic patient.
Measure Definition
This measure assesses the extent to which patients, ages 5-17 with a diagnosis of diabetes had a Hemoglobin 
A1c (HbA1c) test during the measurement year. To be included, children must be continuously enrolled 
in MaineCare (i.e. enrolled for at least 11 out of the 12 months of the measurement year). Children with 
diabetes can be identified based either on pharmacy data or claims; children who were dispensed insulin or 
oral hypoglycemics/anti-hyperglycemics or those with a diagnosis of diabetes on one or more claims are used to 
identify children with diabetes.
Results 
Figure 12 shows the results for the diabetes testing measure, rates have remained fairly stable over the past five 
years. With the exception of a low of 75 percent in 2009 and a high of 84 percent in 2012, rates for annual 
HbA1c testing for children between the ages of 5 and 17 with diabetes have consistently hovered around 80 
percent.
28  2011 National Diabetes Fact Sheet. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
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Figure 12
Annual HbA1c Testing for Children with Diabetes
(Ages 5 - 17)
Source: MaineCare Claims Data
The average number of tests per child was 2.8 in FFY 2013, the same as in FFY 2012 but a slight increase from 
previous years. Also notable is the fact that there are relatively few children enrolled in MaineCare identified as 
having diabetes—ranging from 371 in FFY 2009 to 395 in FFY 2013.
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Figure 13
Average Number of Diabetes Tests
Per Member Per Year
Source: MaineCare Claims Data
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Follow-up after Hospitalization for Mental Illness
CHIPRA Measure FUH / IHOC Measure 44 
Background
Mental health disorders are an important public health issue because of their prevalence, early onset, and impact 
on child, their families and the community, with an estimated total annual cost of $247 billion.29 In any 
given year, between 13 to 20 percent of children living in the United States experience a mental disorder and 
research shows that the prevalence of these conditions among children has continued to increase over the past 
two decades.30 Attention-deficit/hyperactivity disorder (6.8%) was the most prevalent parent-reported current 
diagnosis among children aged 3–17 years, followed by behavioral or conduct problems (3.5%), anxiety (3.0%), 
depression (2.1%), and autism spectrum disorders (1.1%).31 In 2006, the most common conditions for which 
children with Medicaid were hospitalized in community hospitals were mood disorders and ADHD/disruptive 
behaviors.32 Follow-up care after hospitalization is necessary to maintain children’s mental health and continuity 
of care in the community. In addition, follow-up care aids in reducing health care cost by decreasing the rate of 
re-hospitalizations. 
Measure Definition
This measure assesses whether individuals aged 6-20 years who have had a mental hospitalization and were 
discharged from the hospital had an outpatient visit, intensive outpatient encounter, or partial hospitalization 
with a mental health practitioner within 7 or 30 days after discharge (two rates are reported). To be eligible for 
this measure, the child must be continuously enrolled in MaineCare from the day of discharge through 30 days 
after.
Results
Figure 14 shows the total number of hospitalizations for mental illness for FFY 20009 through 2013; this is the 
denominator for the measure. Hospitalizations have continued to steadily decrease from 1,148 in FFY 2009 to 
712 in 2013. 
29-31  Information gathered from the Center for Disease Control report, Mental Health Surveillance Among Children- United States, 2005 – 2001. 
Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/su6202a1.htm.
32  Lasky, T., Krieger, A., Elixhauser, A. & Vitiello, B (2011). Children’s hospitalizations with a mood disorder diagnosis in general hospitals in 
the United States 2000-2006. Child Adolescent Psychiatry Mental Health. 2011; 5: 27. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3162503/.
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Figure 14
Number of Hospitalizations for Mental Illness
(Ages 6 - 20)
Source: MaineCare Claims Data
The actual measure results are displayed in Figure 15, and show that in FFY 2013, the 7-day follow-up rates 
were 80 percent, and the 30-day follow-up rate was 92 percent. Rate for both 7-day and 30-day follow-up have 
continued to grow since 2009. Seven day follow-up rates have increased by 21 percent since 2009 and thirty day 
follow-up rates are up sixteen percent.
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Figure 15
Follow-Up After Child's Hospitalization for Mental Illness
(Ages 6 - 20)
Source: MaineCare Claims Data
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Timeliness and Frequency of Prenatal Care
CHIPRA Measures PPC, FPC / IHOC Measures 46, 47
Background
Early prenatal care (in the first trimester of pregnancy) helps prevent premature birth and other infant health 
problems, as well as, helps improve the health of women during pregnancy.
Measure Definition
These measures assess the timeliness and frequency of prenatal care that MaineCare-enrolled women received 
for all deliveries during the measurement year (calendar year). Timeliness measures the number of MaineCare-
enrolled women in the denominator sample who had a prenatal visit in the first trimester or within 42 days of 
enrollment.33
The Frequency of Ongoing Prenatal Care measure is computed based on the number of reported prenatal care 
visits on the birth certificate and the expected number of visits for the period between when care began and the 
date of delivery. The expected number of visits is based on guidelines for perinatal care defined by the American 
Academy of Pediatrics (AAP) and the American College of Obstetricians and Gynecologists (ACOG). The 
measure categorizes births where the mother received less than 21% of the expected visits; 21-80%; or more 
than 81% of the expected visits. Those in the last category are usually defined as having received “adequate” 
prenatal care.
Results 
Vital statistics data for 2013 is currently not available so the results presented below only include information 
on the timeliness and frequency of prenatal care for FFYs 2009 -2012. Figure 16 shows that almost 100 percent 
of MaineCare deliveries were to mothers who received prenatal care in the first trimester of their pregnancy.
33  Because of limitations with the self-reported prenatal care information available in the Vital Statistics data, we had to make some modifications 
to the CHIPRA measure specifications to compute these two measures. The Vital Statistics data only included a total count of prenatal visits received 
during the pregnancy, and the month in which the first visit was received (e.g. 1 through 9). For the timeliness measure, we counted all mothers who 
reported their first prenatal visit in month 1,2 or 3 OR who reported their first visit as taking place within 2 months of MaineCare enrollment as 
meeting numerator criteria. For the frequency of ongoing prenatal care measure, we only adjusted the number of expected visits based on gestational 
age at delivery (with no adjustment for date of enrollment in MaineCare). Essentially, we made a simplifying assumption that all prenatal care visits 
were covered by MaineCare for deliveries identified in the denominator.
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Timeliness of Prenatal Care
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Source: MaineCare Eligibility and Vital Statistics Data
The frequency of prenatal care among MaineCare recipients has remained consistent since 2009. Figure 17 
shows that over the past five years, approximately 87 percent of those deliveries who received an “adequate” 
number of prenatal visits according to the AAP/ACOG.
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Frequency of Ongoing Prenatal Care
(Expected Visits)
Source: MaineCare Eligibility and Vital Statistics Data
Live Births Weighing Less than 2,500 Grams 
CHIPRA Measure LBW / IHOC Measures 48
Background
Low birth weight (often used as a proxy for premature birth) is an important condition that is highly prevalent. 
Low birth weight is an important predictor of health outcomes for infants, and it is costly to the health care 
system and society. 
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Measure Definition
This measure assesses the percentage of live births per year to women enrolled in MaineCare that weighed less 
than 2,500 grams (5.5 pounds) during the calendar year.
Results
Vital statistics data for 2013 is currently not available so the results presented below only include information 
for FFYs 2009 -2012. Figure 18 shows that just over 7 percent of babies born to MaineCare-enrolled mothers 
in calendar year 2012 were low birth weight, a slight decrease from 2011 were rates were nearly 8 percent.
7.2%
7.9%
7.4%
0%
1%
2%
3%
4%
5%
6%
7%
8%
CY 2010
(n=6,932)
CY 2011
(n=6,941)
CY 2012
(n=6,808)
Pe
rc
en
ta
ge
 o
f M
ai
ne
Ca
re
 B
irt
hs
Figure 18
Percentage of Live Births
Weighing Less than 2500 Grams
Source: MaineCare Eligibility and Vital Statistics Data
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Developmental Screening in the First Three Years of Life
CHIPRA Measure DEV / IHOC Measures 7, 8 and 10
Background
In the United States, about 13 percent of children 3 to 17 years of age have a developmental or behavioral 
disability such as autism, intellectual disability or ADHD.34 An estimated 9.5 million Medicaid- and CHIP-
enrolled preschool children are eligible for developmental screening. In the United States, 17 percent of children 
(12 million children) were found to have a behavioral disability such as autism, mental retardation, or attention-
deficit/hyperactivity disorder. Medicaid serves more than 25 percent of all children in the United Sates (and 
more than half of all poor and low-income children). Children from poor families are at greater risk than 
those from non-poor families for poorer outcomes, including those related to mental development. The 2007 
National Survey of Children’s Health (NSCH) found that publicly insured children were 1.9 times as likely as 
privately insured children (18.3 percent versus 9.7 percent, respectively) to have one or more of six specified 
learning, developmental, or behavioral conditions.35
Measure Definition
This measure assesses the extent to which children at various young ages from 0-36 months were screened 
for social and emotional development with a standardized, documented tool or set of tools. Eligible children 
include those who turn age 1, age 2, or age 3 and who were enrolled continuously in MaineCare during the 
measurement year. For claims-based reporting, screening is identified using CPT code 96110.
Results 
The results for the developmental screening of children who turn 1, 2 and 3 years old during the measurement 
year are shown in Figures 19 and 20. The rates have significantly increased over the past three years.36
34 Information gathered from the Center for Disease Control report, Developmental Monitoring and Screening. Available at: http://www.cdc.gov/
ncbddd/childdevelopment/screening.html.
35  Background Report for the Initial, Recommended Core Set of Children’s Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs. 
Available at: http://www.ahrq.gov/policymakers/chipra/overview/background/corebackgrnd.pdf
36  Because of changes to measure specifications, only comparable data is presented (2011-2012).
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Figure 19
Developmental Screening Rates Among
MaineCare-Enrolled Children
Source: MaineCare Claims Data
The percentage of children who were screened for risk of developmental, behavioral and social delays using a 
standardized tool on or before their 1st birthday increased from 1.7 percent in FFY 2011 to 12.5 percent in FFY 
2013. One year old screening rates were over 6 times higher in 2013 than they were in 2011. Rates of screening 
for children after their 1st birthday and on or by their second birthday were nearly seven times higher in FFY 
2013 than they were in FFY 2011, increasing from 2.48 percent to 17.11 percent. For children between their 
2nd and 3rd birthday’s rates increased nearly tenfold going from 1.14 percent in FFY 2011 to 11.93 percent in 
FFY 2013.
Summary of Pediatric Quality Measures for Children Enrolled in MaineCare
Muskie School of Public Service       Cutler Institute for Health and Social Policy 33
FFY2011 FFY2012 FFY2013
2 - < 3 Years 35 104 752
1  - < 2 Years 226 372 1,066
0 - < 1 Year 141 212 803
0
500
1,000
1,500
2,000
2,500
3,000
N
um
be
r o
f C
hi
ld
re
n 
Sc
re
en
ed
Total: 405
Total:688
Total: 2,621
Figure 20
Number of Children With Developmental Screening
Documented in MaineCare Claims (CPT 96110)
Source: MaineCare Claims Data
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Consumer Assessment of Healthcare Providers and Systems® 
(CAHPS) 4.0h 
CHIPRA Measure CPC / IHOC Measures 51
Background
The main purpose of the annual Survey of Children Served by MaineCare is to monitor the quality of services 
delivered by MaineCare, the state of Maine’s Medicaid and Child Health Insurance (CHIP) program. The 
2013 survey uses a standardized instrument---the Consumer Assessment of Healthcare Providers and Systems 
(CAHPS 4.0H)—as its primary means of examining the experiences of families with children enrolled in 
MaineCare. The CAHPS 4.0H is designed to provide feedback to Medicaid fee-for-service and managed care 
plans by identifying performance dimensions in which they excel and areas in which they need improvement. 
The 2013 survey included children aged 17 or younger who were enrolled in MaineCare for at least 5 months 
between September 2012 and February 2013. 
In addition to CAHPS, Maine’s annual survey includes supplemental questions that focus on priority areas 
for the Department including the degree to which providers discuss recommended preventive topics at well-
child visits, the prevalence of childhood obesity ant tobacco use/second-hand smoke exposure among children 
served by MaineCare, oral health access and unmet need, the affordability of Children’s Health Plan premiums, 
and availability/access to employer-sponsored health insurance. Of the total 2,413 eligible families who were 
contacted, 1,077 interviews were completed, for an overall response rate of 44.6 percent.
Measure Definition
This measure provides information on parents’ experience with their child’s health plan. Results summarize 
member experiences through ratings, composites and individual question summary rates. Topics covered in 
the survey include: rating of all health care and personal doctor, customer service, getting care quickly, getting 
needed care, how well doctors communicate, shared decision making, family centered care, coordination of care 
for children with chronic conditions, and access to prescription medicines.
Results
• MaineCare higher than the national average on most patient experience measures. As in the previous 
year, MaineCare’s patient experience scores compared favorably to those of other state child Medicaid 
programs37 on CAHPS measures related to providing needed care, providing care quickly, doctor’s 
communication skills, and doctor’s knowledge of the child, with ratings at or above the 75th percentile on 
all the composites and individual items in these four areas. Overall ratings of the child’s personal doctor 
and of health care professionals’ provision of information were also among the highest nationally (at or 
above the 75th percentile).
37  National comparisons are based on the latest available national CAHPS data available as of the writing of this report, which was for 2011.
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• Significant improvements in MaineCare provider/family communication and care coordination. 
Compared to last year, the percentage of parents who reported that the child’s personal doctor consistently 
spent enough time with the child increased from 75 percent in 2012 to 82 percent in 2013. Moreover, 
the proportion of parents indicating that providers always answered their questions increased from 80 
percent to 85 percent. The percentage of those stating that they received help with care coordination also 
improved, increasing from 41 percent to 49 percent.
• MaineCare lower than national average on customer service, availability of treatment choices, 
and care coordination among providers. As in the previous year’s survey, only half (49%) of parents 
reported that customer service at MaineCare consistently provided the information or help they needed. 
MaineCare’s score on this item fell in the 25th-50th percentile range nationally. However 69 percent of 
parents said that customer service staff were always courteous and respectful, which was above the national 
average and a significant improvement over the prior year (59%). 
• Many MaineCare children have special health care needs. Thirty-five percent of children enrolled in 
MaineCare have special health care needs, according to the 2013 survey. Although this prevalence estimate 
is lower than the 2012 survey’s estimate of 39 percent, it still far exceeds the prevalence of special health 
care needs in the general population of children in Maine (19.4%).
• For nearly three quarters of MaineCare children, physicians discussed physical activity, nutrition/ diet, 
avoiding sugar-sweetened drinks. Physicians also discussed television viewing and other screen time with 
two thirds of Maine Care Children. Survey results indicate that for children who are overweight, providers 
are even more likely to discuss issues to encourage healthy behaviors. These rate were comparable or slightly 
higher, although not significantly than in the prior year survey.
• Significant increase in discussion of mental health during well-child visits. Sixty percent of parents 
indicated that their child’s provider discussed mental health issues with the child or parent, which was a 
significant increase from 53 percent the previous year (p<0.05). Discussions of use of tobacco products 
(60%), drug and alcohol use (57%) and reproductive health (48%) at recommended ages during well-child 
visits also all increased over the prior year, although not significantly. 
• Majority of MaineCare children get dental care and give high ratings on quality of care received. 
Nearly two-thirds (62%) of all children enrolled in MaineCare received dental services in the past six 
months, and one in five (20%) had more than one visit with a dental provider. By comparison, in a study 
using 2008 Medicaid administrative data from nine states, 34 percent of children had a dental preventive 
service and 19 percent had used a dental treatment service provided by Medicaid in the past year.38 For 
those MaineCare members that received dental services in 2013, had a usual source of dental care (77%) 
and the overall rating of the child’s dental care was quite high, with a mean score of 8.9 on a scale of 1 to 
10, and 68 percent of respondents rating the quality of their child’s dental care a 9 or 10.
38  Bouchery, E., Utilization of dental services among Medicaid-enrolled children. Medicare and Medicaid Research Review, 2013; 3:E1-E15. Available 
at http://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/MedicaidDataSourcesGenInfo/Downloads/MAX_IB9_
DentalCare.pdf . [Retrieved 12/14/2013.]
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APPENDIX A: IHOC AND CHIPRA RESULTS FOR FFY 2009-2013
Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate
ADD_INI_PCT HEDIS Follow-Up Care for Children Prescribed ADHD Medication (Initial Phase) 628 1,271 49.41% 855 1,346 63.52% 975 1,463 66.64% 1,026 1,565 65.56% 1,114 1,645 67.72%
ADD_CM_PCT HEDIS
Follow-Up Care for Children Prescribed ADHD Medication                                   
(Continuaiton & Maintenance Phase) 551 1,189 46.34% 765 1,274 60.05% 878 1,387 63.30% 922 1,482 62.21% 1,008 1,564 64.45%
ASM_5_PCT HEDIS Use of Appropriate Medications for People With Asthma (5-12) 1,259 1,353 93.05% 1,369 1,465 93.45% 1,512 1,626 92.99% 1,523 1,612 94.48% 684 729 93.83%
ASM_12_PCT HEDIS Use of Appropriate Medications for People With Asthma(12-21) 1,160 1,304 88.96% 1,213 1,386 87.52% 1,239 1,437 86.22% 1,240 1,438 86.23% 597 675 88.44%
ASM_TOT_PCT HEDIS Use of Appropriate Medications for People With Asthma (Total) 2,419 2,657 91.04% 2,582 2,851 90.56% 2,751 3,063 89.81% 2,763 3,050 90.59% 1,281 1,404 91.24%
AWC_PCT HEDIS Adolescent Well-Care Visits 16,502 43,402 38.02% 16,785 46,469 36.12% 19,434 49,188 39.51% 18,528 47,990 38.61% 18,008 46,350 38.85%
CAP_12M_PCT HEDIS Children and Adolescents’ Access to Primary Care Practitioners 6,643 6,822 97.38% 7,111 7,329 97.03% 7,259 7,529 96.41% 6,850 7,048 97.19% 6,498 6,736 96.47%
CAP_25M_PCT HEDIS Children and Adolescents’ Access to Primary Care Practitioners 25,177 28,715 87.68% 27,153 31,229 86.95% 29,153 33,116 88.03% 28,548 32,438 88.01% 27,552 31,302 88.02%
CAP_7_PCT HEDIS Children and Adolescents’ Access to Primary Care Practitioners 21,463 23,901 89.80% 22,517 24,999 90.07% 24,789 27,109 91.44% 25,599 27,788 92.12% 25,669 27,821 92.26%
CAP_12_PCT HEDIS Children and Adolescents’ Access to Primary Care Practitioners 30,580 34,457 88.75% 32,068 36,025 89.02% 34,660 38,590 89.82% 35,178 38,996 90.21% 35,035 38,602 90.76%
CDC_H5_P1MT HEDIS Comprehensive Diabetes Care- HbA1c Testing 280 371 75.47% 294 368 79.89% 329 408 80.64% 339 404 83.91% 314 395 79.49%
CDC_H5_ATPM HEDIS Comprehensive Diabetes Care - HbA1c Average number of test per member 854 371 2.30 928 368 2.30 1,024 408 2.51 1,117 404 2.76 926 395 2.76
CHL_16_PCT HEDIS Chlamydia Screening 3,877 8,549 45.35% 3,663 8,974 40.82% 3,891 9,218 42.21% 3,315 8,403 39.45% 3,039 7,121 42.68%
CWP_PCT HEDIS Appropriate Testing for Children With Pharyngitis 716 994 72.03% 745 992 75.10% 1,040 1,303 79.82% 946 1,171 80.79% 651 819 79.49%
CHIPRA 
Measure Specifications Measure Description 
FFY 2009 FFY 2010 FFY 2011 FFY 2012 FFY 2013
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APPENDIX A: IHOC AND CHIPRA RESULTS FOR FFY 2009-2013 (CONTINUED)
Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate Numerator Denominator % or Rate
DPS CHIPRA Total Eligibles Who Received Preventive Dental Services (0 - 20)* 24,399 123,555 19.75% 41,165 128,418 32.06% 41,422 123,250 33.61% 40,957 129,026 31.74%
DTS CHIPRA Total Eligibles Who Received Dental Treatment Services (0 - 20)* 13,431 123,555 10.87% 21,635 128,418 16.85% 22,537 123,250 18.29% 21,973 129,026 17.03%
DS3 CHIPRA Developmental Screening - Age 3 78 6,820 1.14% 104 6,617 1.57% 752 6,306 11.93%
FUH_7D_PCT HEDIS Follow-Up After Hospitalization for Mental Illness (7 day f/u) 567 1,148 49.39% 507 1,012 50.10% 701 878 79.84% 729 910 80.11% 567 712 79.63%
FUH_30D_PCT HEDIS Follow-Up After Hospitalization for Mental Illness (30 day f/u) 867 1,148 75.52% 787 1,012 77.77% 827 878 94.19% 854 910 93.85% 655 712 91.99%
PPC CHIPRA Timeleness of Prenatal Care (All Ages) 6,259 6,370 98.26% 6,230 6,374 97.74% 6081 6213 98%
FPC CHIPRA Frequency of Prenatal Care: 0 - 20% of expected prenatal visits 86 6,370 1.35% 124 6,374 1.95% 136 6213 2%
FPC CHIPRA Frequency of Prenatal Care: 21 - 80% of expected visits 766 6,370 12.03% 734 6,374 11.52% 712 6213 11%
FPC CHIPRA Frequency of Prenatal Care: >=81% of expected visits 5,518 6,370 86.62% 5,516 6,374 86.54% 5365 6213 87%
LBW CHIPRA Percentage of live births weighing less than 2500 grams (All ages) 501 6,932 7.23% 548 6,941 7.90% 503 6808 100%
W34_PCT HEDIS Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life 14,762 23,124 63.84% 15,505 25,304 61.27% 17,241 26,845 64.22% 16,492 26,526 62.17% 16,176 25,788 62.73%
WC711 IHOC Well Child Visits between 7 years of age and 11 years of age 12,754 27,246 46.81% 12,950 28,856 44.88% 14,748 30,590 48.21% 14,713 30,811 47.75% 14,768 30,432 48.53%
APER CHIPRA
Annual Number of Asthma Patients with > 1 asthma-related Emergency Room 
Visit 881 11,817 7.46% 874 12,719 6.87% 1,082 11,939 9.06% 1,009 11,799 8.55% 671 9,479 7.08%
Measure Description 
FFY 2009 FFY 2010 FFY 2011 FFY 2012CHIPRA 
Measure Specifications
FFY 2013
Vital Statistics Data for 2013 is Currently Not 
Avalible
*Note: Dental measure results come from the CMS 416 / EPSDT Annual Reports (Lines 12b and 12c)
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APPENDIX A: IHOC AND CHIPRA RESULTS FOR FFY 2009-2013 (CONTINUED)
Visits Member Months % or Rate Visits
Member 
Months % or Rate Visits 
Member 
Months % or Rate Visits
Member 
Months % or Rate Visits
Member 
Months % or Rate
0 131 2.1% 0 151 2.3% 0 159 2.1% 0 185 2.9% 0 173 3%
1 106 1.7% 1 97 1.5% 1 105 1.6% 1 115 1.8% 1 109 2%
2 165 2.7% 2 194 3.0% 2 190 2.8% 2 188 2.9% 2 154 2%
3 268 4.4% 3 278 4.3% 3 288 4.3% 3 309 4.8% 3 258 4%
4 532 8.7% 4 562 8.6% 4 600 9.5% 4 499 7.8% 4 498 8%
5 1,001 16.4% 5 1,082 16.6% 5 1,110 16.9% 5 951 14.9% 5 869 14%
6+ 3,908 64.0% 6+ 4,162 63.8% 6+ 4,206 62.8% 6+ 4,148 64.9% 6+ 4,249 67%
TOTAL 6,111 100% TOTAL 6,526 100% TOTAL 6,658 100% TOTAL 6,395 100% TOTAL 6,310 100%
0 653 11.2% 0 753 11.5% 0 810 11.3% 0 655 9.9% 0 597 9.6%
1 972 16.7% 1 1,138 17.5% 1 1,140 16.7% 1 1,000 15.1% 1 861 13.9%
2 1,538 26.4% 2 1,712 26.3% 2 1,724 25.4% 2 1,660 25.1% 2 1,382 22.3%
3 + 2,663 45.7% 3 + 2,917 44.7% 3 + 3,146 46.5% 3 + 3,302 49.9% 3 + 3,357 54.2%
TOTAL 5,826 100% TOTAL 6,520 100% TOTAL 6,820 100% TOTAL 6,617 100% TOTAL 6,197 281%
W15
WC24
CHIPRA 
Measure Specifications Measure Description 
HEDIS Well-Child Visits in the First 15 Months of Life
HEDIS Well Child Visits between 15 months and 3 years of age
FFY 2009 FFY 2010 FFY 2011 FFY 2012 FFY 2013
Visits Member Months
Visits/1,000 
MM Visits
Member 
Months % or Rate Visits 
Member 
Months Visits/1,000 MM Visits
Member 
Months
Visits/1,000 
MM Visits
Member 
Months
Visits/1,000 
MM
Emergency Department (ED) Utilization- Average number of ED visits per 1,000 
member months (MM)
          age1 ( <1) 3,798 47,206 80.5 3,499 46,728 74.9 3,327 44,640 74.5 3,119 45,461 68.6 2,907 46,002 40.2
          age1-9 (>=1 to < 10) 39,922 701,139 56.9 42,071 737,854 57.0 39,009 742,544 52.5 39,890 768,991 51.9 36,669 750,813 53.4
          age10-19 (>=10 to < 20) 35,956 689,193 52.2 36,833 721,229 51.1 33,661 717,337 46.9 33,015 743,866 44.4 29,784 724,679 44.5
TOTAL 79,676 1,437,538 55.4 82,403 1,505,811 54.7 75,997 1,504,521 50.5 76,024 1,558,318 48.8 69,360 1,521,494 45.6
FFY 2010 FFY 2011 FFY 2012 FFY 2013
Measure Description 
FFY 2009
